CGT Catapult teams with Korecyte Bio on low-oxygen detecting CAR-T program
By
Millie Hoe
1mo agoen
Source
bioprocessintl.comCGT Catapult teams with Korecyte Bio on low-oxygen detecting CAR-T programbioprocessintl.comA startup biotech company out of King’s College London is using hypoxia to target solid tumors.
You might also wanna read

AI-guided discovery identifies GPNMB as promising CAR T cell target for multiple cancers
Researchers developed an AI-driven framework for discovering CAR T cell therapy targets by integrating single-cell RNA sequencing data from
cell.com·12d ago
Greater Bay Area emerges as launchpad for China's biotech rise
shanghaisun.com·4d ago
Dual tumour–myeloid targeting of glioblastoma with GPNMB CAR-T cells
Nature Communications·7d ago
CMU Startup Pierogi Therapeutics Uses AI to Accelerate Radiopharmaceutical Cancer Drug Discovery
A Carnegie Mellon University startup called Pierogi Therapeutics is using AI and advanced chemistry to accelerate the discovery of cancer dr
Study Shows Low-Cost Portable Biotech Tools Can Expand Access to Research and Diagnostics in Resource-Limited Settings
A global research team led by University of Toronto's Leslie Dan Faculty of Pharmacy has demonstrated the effectiveness of low-cost, portabl
British startup sends biology lab to orbit to gather microgravity protein data for AI models targeting Alzheimer's and cancer
A British startup has launched a biology laboratory into low-Earth orbit to collect microgravity protein data and transmit it back to Earth.

Comments
Sign in to join the conversation.
No comments yet. Be the first.